Fuan Pharmaceutical Group Co (300194) — Strategic Asset Allocation Index
Fuan Pharmaceutical Group Co (300194) has a Strategic Asset Allocation Index of 42.0% as of June 2023. Strategic assets (PP&E of CN¥1.71 Billion plus long-term investments of CN¥-) total CN¥1.71 Billion, measured against net assets of CN¥4.07 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Fuan Pharmaceutical Group Co (300194) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Fuan Pharmaceutical Group Co Strategic Asset Allocation Index (2008–2021)
This chart shows how Fuan Pharmaceutical Group Co's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 42.0%, representing strategic assets of CN¥1.71 Billion against net assets of CN¥4.07 Billion CNY. See Fuan Pharmaceutical Group Co leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Fuan Pharmaceutical Group Co (2008–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Fuan Pharmaceutical Group Co from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Fuan Pharmaceutical Group Co market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 37.4% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥3.87 Billion | ▲ +10.6 pp |
| 2020 | 26.8% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥4.56 Billion | ▼ -11.3 pp |
| 2019 | 38.1% | CN¥1.52 Billion | CN¥940.46 Million | CN¥579.84 Million | CN¥3.99 Billion | ▼ -0.8 pp |
| 2018 | 38.9% | CN¥1.44 Billion | CN¥943.23 Million | CN¥494.04 Million | CN¥3.69 Billion | ▲ +3.1 pp |
| 2017 | 35.8% | CN¥1.49 Billion | CN¥1.01 Billion | CN¥483.90 Million | CN¥4.17 Billion | ▼ -3.2 pp |
| 2016 | 39.0% | CN¥1.55 Billion | CN¥1.06 Billion | CN¥482.50 Million | CN¥3.96 Billion | ▲ +4.2 pp |
| 2015 | 34.8% | CN¥744.08 Million | CN¥744.08 Million | CN¥- | CN¥2.14 Billion | ▲ +3.6 pp |
| 2014 | 31.3% | CN¥534.04 Million | CN¥534.04 Million | CN¥- | CN¥1.71 Billion | ▼ -2.6 pp |
| 2013 | 33.9% | CN¥584.86 Million | CN¥584.86 Million | CN¥- | CN¥1.72 Billion | ▲ +9.1 pp |
| 2012 | 24.8% | CN¥426.15 Million | CN¥426.15 Million | CN¥- | CN¥1.72 Billion | ▲ +4.0 pp |
| 2011 | 20.7% | CN¥350.76 Million | CN¥350.76 Million | CN¥- | CN¥1.69 Billion | ▼ -34.7 pp |
| 2010 | 55.4% | CN¥155.69 Million | CN¥155.69 Million | CN¥- | CN¥281.05 Million | ▼ -17.0 pp |
| 2009 | 72.4% | CN¥118.25 Million | CN¥118.25 Million | CN¥- | CN¥163.31 Million | ▼ -9.5 pp |
| 2008 | 81.9% | CN¥90.73 Million | CN¥90.73 Million | CN¥- | CN¥110.76 Million | — |